MDNAF
Medicenna Therapeutics Corp

1,055
Mkt Cap
$48.32M
Volume
134,899.00
52W High
$1.43
52W Low
$0.546
PE Ratio
-6.24
MDNAF Fundamentals
Price
$0.682
Prev Close
$0.703
Open
$0.683
50D MA
$0.6817
Beta
0.82
Avg. Volume
87,739.35
EPS (Annual)
-$0.1107
P/B
12.94
Rev/Employee
$0.00
$35.07
Loading...
Loading...

About

Medicenna Therapeutics Corp. is a clinical stage immuno-oncology company. It engages in development and commercialization of selective versions of IL-2, IL-4 and IL-13 Superkines and Empowered Cytokines for the treatment of cancers. The company was founded by Fahar Merchant and Rosemina Merchant on February 2, 2015 and is headquartered in Toronto, Canada.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
18

Frequently Asked Questions

What is Market Cap of Medicenna Therapeutics Corp?
What is the 52-week high for Medicenna Therapeutics Corp?
What is the 52-week low for Medicenna Therapeutics Corp?
What is Medicenna Therapeutics Corp stock price today?
What was Medicenna Therapeutics Corp stock price yesterday?
What is the PE ratio of Medicenna Therapeutics Corp?
What is the Price-to-Book ratio of Medicenna Therapeutics Corp?
What is the 50-day moving average of Medicenna Therapeutics Corp?
How many employees does Medicenna Therapeutics Corp have?

Latest MDNAF News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.